Patients with myeloma do gain protection from the COVID-19 vaccines, according to a new study conducted by the Institute of Cancer Research in London. Immune responses were observed in 70% of the 93 myeloma patients treated at the Royal Marsden Hospital.
Doctors have reported concerns about the effectiveness of the vaccine for myeloma patients, worried that the vaccines offer no protection against the virus.
However, the research found that 52 patients tested positive for IgG antibodies against COVID-19 after their first vaccination. Further testing of 40 of the people who were negative of IgG antibodies revealed another 13 patients who were positive for other antibodies against the virus, giving a total of 65 out of...
10 days ago
Patients with myeloma do gain protection from the COVID-19 vaccines, according to a new study conducted by the Institute of Cancer Research in London. Immune responses were observed in 70% of the 93 myeloma patients treated at...
10 days ago
Researchers have discovered a potential route to prevent the development of ‘inhibitor’ antibodies to coagulation factor VIII therapy for haemophilia A.
Although factor VIII (FVIII) replacement therapy prevents bleeding-related...
10 days ago